Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Stock markets: The month that was - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Oct 7, 2004

    Stock markets: The month that was

    While there seems to be a fair sprinkling of pessimism over the fate of the global economy owing to record high crude prices and the threat of inflation arising from it, the Indian stock markets appear to be the proverbial paradox.

    Riding on the back of expectations of another round of strong quarterly results and more recently, a robust 7.4% GDP growth during 1QFY05, the benchmark indices have shrugged the twin demons of inflation and crude prices and have pocketed a cool 9% gain over the past one month. However, not all Sensex stocks have risen by the same rate and some of them have outperformed the index by a considerable margin. In this article, let us have a look at the top five gainers on the Sensex in the past one month and see whether the buoyancy is justified or not.

      3-Sept'04 6-Oct'04 % change
    Sensex 5,246 5,722 9.1%
    Nifty 1,644 1,795 9.2%
    Cipla 236 288 21.6%
    HDFC 567 668 17.8%
    Tata Steel 253 290 14.7%
    Reliance 477 547 14.7%
    HLL 112 127 13.6%

    Cipla: Leading the brigade with an impressive 22% gain is Cipla, the newly anointed number one pharma company in the domestic markets. It has caught the investor's fancy in recent times owing to the consistency in its growth and margins over the last few quarters. On the other hand, rivals like Ranbaxy and Dr Reddy's have grown at a much lower rate on account of differences in their business models. While the latter two rely more on generics business in regulated markets, Cipla is focused on formulation sales in the unregulated markets and also employs a low risk strategy of partnering with generics major in US for supply of bulk drugs. Hence, there is a greater visibility to the company's revenues. However, over the long-term, we believe that Cipla's profitability might get hurt because of its dependence on bulk drugs, entry barriers to which are pretty low. Hence, the low cost expertise that Cipla currently enjoys will not be too difficult to replicate.

    HDFC: With gains of 17%, HDFC, India's largest housing finance company occupies the second spot. Owing to uncertainty over interest rates, the stock had shown little movement during the early part of the year. But with demand for housing loans continuing to remain robust, the stock seems to have come right back into contention. With housing loan disbursals expected to grow in the region of 25% over the next few years on account of significant shortfall in dwelling units, this presents a great opportunity for a quality player like HDFC. Moreover, its investments in companies such as HDFC Bank and HDFC Standard Life Insurance is likely to hold it in good stead going forward.

    Tata Steel: The company, which is one of the world's low cost steel producers, is the third highest gainer on the bourses (15% over the last one month). With metal prices once again threatening to reach record highs, investors seem to be making a beeline for the stock. Moreover, the company recently acquired Natsteel, a Singapore based steel company, which is likely to give Tisco an opportunity to further diversify and service select South East Asian markets. Having said that, we would urge the investors to be circumspect at these levels, as the risk return ratio currently seems skewed towards risk.

    Reliance: India's leading private sector player has gained nearly 15% in the last one month. The optimism could be attributed to the uptrend in the petrochemical cycle, which has led to increase in prices, a positive for an integrated player like Reliance. Besides, there has been no significant capacity addition in recent past as well. Moreover, the company's other investments in telecom businesses and exploration projects are also a positive.

    HLL: The FMCG major is the fifth highest gainer on the bourses over the last one month. FMCG stocks were not exactly hot property in the recent bull rally. Demand in rural areas, which was expected to pick up post favorable monsoons in FY03, did not exactly materialize. Moreover, with archrival P&G slashing detergent prices by half, the company had to follow suit and this made the going even tougher for the company. However, recently, both the companies revisited their strategy and have raised prices. However, we believe that though the company may be able to tide over the short-term pricing blues, margins are unlikely to reach the past highs.

    Having looked at the top five gainers and the overall market sentiment over the past one month, we feel that one has to exercise caution at current levels. Although, the fundamentals are good, some stocks seem to have run ahead of their valuations and hence, have started looking expensive even from a medium term perspective.



    Equitymaster requests your view! Post a comment on "Stock markets: The month that was". Click here!


    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Were You Lured By Mr Market's Bait? (The 5 Minute Wrapup)

    Aug 23, 2017

    Mr Market lured investors into believing they'd bitten into a crash. Did you take the bait?

    Deep State First (Vivek Kaul's Diary)

    Aug 23, 2017

    Nowhere was the darkness deeper than in the nation's capital. There, no light shone. No flicker of awareness...observation...learning...or reflection appeared.

    Why Hasn't Warren Buffett Rung the Bell Yet? (The 5 Minute Wrapup)

    Aug 22, 2017

    It's surprising Warren Buffett hasn't warned investors about the expensive stock market? Let us know why.

    Think Twice Before You Keep Money In A Savings Bank Account (Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 23, 2017 03:36 PM